Vivos Therapeutics (VVOS) PT Raised to $2.90 at Ascendiant Capital
Tweet
Share
E-mailGet Alerts VVOS Hot Sheet
Price: $0.14 --0%
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 45
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 45
Join SI Premium – FREE
Ascendiant Capital analyst Lucas Ward raised the price target on Vivos Therapeutics (NASDAQ: VVOS) to $2.90 (from $2.80) while maintaining a Buy rating.
You May Also Be Interested In
- Vertex (VRTX) PT Raised to $615 at UBS
- Xencor, Inc. (XNCR) PT Raised to $29 at Truist Securities
- Karman Holdings Inc (KRMN) PT Lowered to $70 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
